India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies

  • 6 patents filed for pain management, eating disorders and epilepsy
  • Additional patents underway for PTSD, depression, Alzheimer’s and Parkinson’s disease
  • Revenue potential of each cannabis-based therapy could fetch between $100 million to $500 million

India Globalization Capital (NYSE AMERICAN: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for the treatment of Alzheimer’s, cachexia, pain, and other life-altering conditions. The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease utilizing novel data (http://cnw.fm/1hUKu). This cannabis-based combination therapy shows promise for Alzheimer’s sufferers, says IGC CEO Ram Mukunda.

“As Alzheimer’s progresses, synaptic dysfunction and the death of neurons lead to memory loss. These study results, when combined with the earlier reported data that shows IGC-AD1 reduces Aβ40 and Aβ42 production by as much as 50%, and 40%, without any toxicity, represent a highly significant novel breakthrough that could potentially bring much needed relief from this devastating disease,” Mukunda says, adding…

Read More >>

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Leave a Reply